{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:21:37Z","timestamp":1783354897546,"version":"3.54.6"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004801","name":"Shota Rustaveli National Science Foundation of Georgia","doi-asserted-by":"crossref","award":["PHDF-22-1332"],"award-info":[{"award-number":["PHDF-22-1332"]}],"id":[{"id":"10.13039\/501100004801","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Humoral responses to COVID-19 vaccination vary across populations, and evidence on the role of ABO and the Rhesus factor remains inconsistent. This prospective cohort study examined peak antibody responses among 175 voluntary plasma donors in Georgia during 2022\u20132023, a setting where the prevalence of Rhesus negativity is relatively high and no prior data have been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Using quantitative anti-spike IgG ELISA, we measured peak antibody titers over a six-month period following vaccination and\/or natural infection. Vaccination emerged as the strongest predictor of high antibody response (\u2265\u20091000 BAU\/mL), with 81.9% of vaccinated versus 21.0% of unvaccinated participants achieving protective levels (OR\u2009=\u200916.88,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Rhesus-positive individuals were significantly more likely to achieve protective titers than Rhesus-negative (57.7% vs. 30.8%,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.011), while ABO blood group showed no association with antibody response (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.374). Hybrid immunity provided optimal protection, with 92.5% of participants achieving elevated titers. These findings highlight vaccination and hybrid immunity as central determinants of humoral response, while identifying the Rhesus factor as an additional contributor. This study represents the first dataset of its kind from the Caucasus region, providing distinct regional evidence with implications for global immunological research.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13104-026-07839-x","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T12:46:51Z","timestamp":1778503611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Strong effect of Anti-COVID-19 vaccination on the peak titer of antibodies against novel coronavirus: factors affecting humoral immunity in Georgian plasma donors"],"prefix":"10.1186","volume":"19","author":[{"given":"Tamar","family":"Azikuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kamkamidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Butsashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikoloz","family":"Pruidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natia","family":"Kvaratskhelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"issue":"7830","key":"7839_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","volume":"586","author":"F Krammer","year":"2020","unstructured":"Krammer F. SARS-CoV-2 vaccines in development. Nature. 2020;586(7830):516\u201327. https:\/\/doi.org\/10.1038\/s41586-020-2798-3.","journal-title":"Nature"},{"issue":"7","key":"7839_CR2","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","volume":"27","author":"DS Khoury","year":"2021","unstructured":"Khoury DS, Cromer D, Reynaldi A, et al. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021;27(7):1205\u201311. https:\/\/doi.org\/10.1038\/s41591-021-01377-8.","journal-title":"Nat Med"},{"issue":"1","key":"7839_CR3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.tmrv.2022.07.002","volume":"37","author":"K Al Sulaiman","year":"2023","unstructured":"Al Sulaiman K, Alsulaiman T, Alnuhait M, et al. Association of ABO and RhD blood groups with COVID-19 susceptibility and severity: A systematic review. Transfus Med Rev. 2023;37(1):34\u201343. https:\/\/doi.org\/10.1016\/j.tmrv.2022.07.002.","journal-title":"Transfus Med Rev"},{"issue":"2","key":"7839_CR4","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1093\/cid\/ciaa1150","volume":"73","author":"J Zhao","year":"2021","unstructured":"Zhao J, Yang Y, Huang H, et al. Relationship between the ABO blood group and coronavirus disease 2019 (COVID-19) susceptibility. Clin Infect Dis. 2021;73(2):328\u201331. https:\/\/doi.org\/10.1093\/cid\/ciaa1150.","journal-title":"Clin Infect Dis"},{"issue":"38","key":"7839_CR5","doi-asserted-by":"publisher","first-page":"e3845","DOI":"10.1097\/MD.0000000000038457","volume":"103","author":"Lack of association","year":"2024","unstructured":"Lack of association. of ABO and RhD blood groups with COVID-19 susceptibility or mortality. Med (Baltim). 2024;103(38):e3845. https:\/\/doi.org\/10.1097\/MD.0000000000038457.","journal-title":"Med (Baltim)"},{"issue":"4","key":"7839_CR6","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00277-023-05317-z","volume":"102","author":"MT Abuawwad","year":"2023","unstructured":"Abuawwad MT, Salem MS, Al Batran MA, et al. Effects of ABO blood groups and Rh-factor on COVID-19 severity and susceptibility: cross-sectional study from South India. Ann Hematol. 2023;102(4):877\u201388. https:\/\/doi.org\/10.1007\/s00277-023-05317-z.","journal-title":"Ann Hematol"},{"issue":"11","key":"7839_CR7","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41577-022-00786-y","volume":"22","author":"R Gaillard","year":"2022","unstructured":"Gaillard R, Bruel T, Dufloo J, et al. Hybrid immunity against SARS-CoV-2 variants. Nat Rev Immunol. 2022;22(11):751\u201363. https:\/\/doi.org\/10.1038\/s41577-022-00786-y.","journal-title":"Nat Rev Immunol"},{"issue":"23","key":"7839_CR8","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1056\/NEJMoa2118946","volume":"386","author":"Y Goldberg","year":"2022","unstructured":"Goldberg Y, Mandel M, Woodbridge Y, et al. Protection and waning of natural and hybrid immunity to SARS-CoV-2. N Engl J Med. 2022;386(23):2201\u201312. https:\/\/doi.org\/10.1056\/NEJMoa2118946.","journal-title":"N Engl J Med"},{"issue":"16","key":"7839_CR9","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","volume":"386","author":"N Andrews","year":"2022","unstructured":"Andrews N, Stowe J, Kirsebom F, et al. Covid-19 vaccine effectiveness against the Omicron variant. N Engl J Med. 2022;386(16):1532\u201346. https:\/\/doi.org\/10.1056\/NEJMoa2119451.","journal-title":"N Engl J Med"},{"issue":"1","key":"7839_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1056\/NEJMoa2203965","volume":"387","author":"LJ Abu-Raddad","year":"2022","unstructured":"Abu-Raddad LJ, Chemaitelly H, Ayoub HH, et al. Effect of hybrid immunity, BNT162b2 vaccination, and prior infection on SARS-CoV-2 Omicron infection. N Engl J Med. 2022;387(1):21\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2203965.","journal-title":"N Engl J Med"},{"issue":"7","key":"7839_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S1473-3099(23)00070-5","volume":"23","author":"SY Tartof","year":"2023","unstructured":"Tartof SY, Slezak JM, Puzniak L, et al. Durability of hybrid immunity against COVID-19. Lancet Infect Dis. 2023;23(7):816\u201326. https:\/\/doi.org\/10.1016\/S1473-3099(23)00070-5.","journal-title":"Lancet Infect Dis"},{"issue":"3","key":"7839_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/s41590-023-01397-2","volume":"24","author":"Y Cao","year":"2023","unstructured":"Cao Y, Yisimayi A, Jian F, et al. Humoral immune response to SARS-CoV-2 variants after infection and vaccination. Nat Immunol. 2023;24(3):547\u201357. https:\/\/doi.org\/10.1038\/s41590-023-01397-2.","journal-title":"Nat Immunol"},{"issue":"32","key":"7839_CR13","doi-asserted-by":"publisher","first-page":"4423","DOI":"10.1016\/j.vaccine.2021.05.063","volume":"39","author":"KA Earle","year":"2021","unstructured":"Earle KA, Ambrosino DM, Fiore-Gartland A, et al. Evidence for antibody as a protective correlate for COVID-19 vaccines. Vaccine. 2021;39(32):4423\u201328. https:\/\/doi.org\/10.1016\/j.vaccine.2021.05.063.","journal-title":"Vaccine"},{"issue":"7865","key":"7839_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41586-021-03739-1","volume":"595","author":"DA Collier","year":"2021","unstructured":"Collier DA, Ferreira IATM, Kotagiri P, et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2. Nature. 2021;595(7865):417\u201322. https:\/\/doi.org\/10.1038\/s41586-021-03739-1.","journal-title":"Nature"},{"issue":"32","key":"7839_CR15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.15585\/mmwr.mm7032e1","volume":"70","author":"AM Cavanaugh","year":"2021","unstructured":"Cavanaugh AM, Spicer KB, Thoroughman D, et al. Reduced risk of reinfection with SARS-CoV-2 after COVID-19 vaccination \u2014 Kentucky, May\u2013June 2021. MMWR Morb Mortal Wkly Rep. 2021;70(32):1081\u201383. https:\/\/doi.org\/10.15585\/mmwr.mm7032e1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"16","key":"7839_CR16","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1056\/NEJMoa2109072","volume":"385","author":"M Bergwerk","year":"2021","unstructured":"Bergwerk M, Gonen T, Lustig Y, et al. Covid-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021;385(16):1474\u201384. https:\/\/doi.org\/10.1056\/NEJMoa2109072.","journal-title":"N Engl J Med"},{"issue":"16","key":"7839_CR17","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1056\/NEJMoa2020283","volume":"383","author":"D Ellinghaus","year":"2020","unstructured":"Ellinghaus D, Degenhardt F, Bujanda L, et al. Genomewide association study of severe Covid-19 with respiratory failure. N Engl J Med. 2020;383(16):1522\u201334. https:\/\/doi.org\/10.1056\/NEJMoa2020283.","journal-title":"N Engl J Med"},{"issue":"11","key":"7839_CR18","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1093\/cid\/ciab381","volume":"73","author":"L M\u00fcller","year":"2021","unstructured":"M\u00fcller L, Andr\u00e9e M, Moskorz W, et al. Age-dependent immune response to the Biontech\/Pfizer BNT162b2 COVID-19 vaccination. Clin Infect Dis. 2021;73(11):2065\u201372. https:\/\/doi.org\/10.1093\/cid\/ciab381.","journal-title":"Clin Infect Dis"},{"issue":"7851","key":"7839_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler C, Wang Z, Lorenzi JCC, et al. Evolution of antibody immunity to SARS-CoV-2. Nature. 2021;591(7851):639\u201344. https:\/\/doi.org\/10.1038\/s41586-021-03207-w.","journal-title":"Nature"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13104-026-07839-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07839-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13104-026-07839-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T16:13:07Z","timestamp":1783354387000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13104-026-07839-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7839"],"URL":"https:\/\/doi.org\/10.1186\/s13104-026-07839-x","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"3 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki. Ethical approval was granted by the University of Georgia Institutional Review Board (reference no. 11-24768). Written informed consent was obtained from all participants prior to inclusion.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. No identifying images or personal details of participants are included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"275"}}